Reply to: “Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters,” by Venkataraman, Janhavi et al.
Hussain A. Abdulla, Ruth S. Prichard, Michael R. Boland
Springer Nature ·
2026-02-23
· DOI 10.1245/s10434-026-19353-2
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Hussain A. Abdulla, Ruth S. Prichard, Michael R. Boland. Reply to: “Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters,” by Venkataraman, Janhavi et al. // Annals of Surgical Oncology. – 2026. – DOI: 10.1245/s10434-026-19353-2. – URL: https://doi.org/10.1245/s10434-026-19353-2
Hussain A. Abdulla, Ruth S. Prichard, & Michael R. Boland (2026). Reply to: “Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters,” by Venkataraman, Janhavi et al. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-19353-2
Hussain A. Abdulla, et al. “Reply to: “Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters,” by Venkataraman, Janhavi et al.” Annals of Surgical Oncology, 2026. doi:10.1245/s10434-026-19353-2.
@article{Abdulla2026,
title = {Reply to: “Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters,” by Venkataraman, Janhavi et al.},
author = {Abdulla, Hussain A. and Prichard, Ruth S. and Boland, Michael R.},
journal = {Annals of Surgical Oncology},
year = {2026},
doi = {10.1245/s10434-026-19353-2},
url = {https://doi.org/10.1245/s10434-026-19353-2}
}